Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact

Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable lifestyle-related disease with high global prevalence. COPD is associated with significant morbidity and mortality worldwide. Comorbidities are important events in the natural history of the disease and have a negativ...

Full description

Bibliographic Details
Main Authors:	Sarkar, Malay, Rajta, Puja Negi, Khatana, Jasmin
Format:	Online
Language:	English
Published:	Medknow Publications & Media Pvt Ltd 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372868/

id	pubmed-4372868
recordtype	oai_dc
spelling	pubmed-43728682015-03-26 Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact Sarkar, Malay Rajta, Puja Negi Khatana, Jasmin Review Article Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable lifestyle-related disease with high global prevalence. COPD is associated with significant morbidity and mortality worldwide. Comorbidities are important events in the natural history of the disease and have a negative effect on the morbidity and mortality of COPD patients. Cardiac diseases, lung cancer, osteoporosis, and depression are common comorbidities reported for COPD. Recently, anemia has been recognized as a frequent comorbidity in COPD patients. The prevalence of anemia in patients with COPD varies from 7.5% to 33%. Anemia of chronic disease (ACD) is probably the most common type of anemia associated with COPD. ACD is driven by COPD-mediated systemic inflammation. Anemia in COPD is associated with greater healthcare resource utilization, impaired quality of life, decreased survival, and a greater likelihood of hospitalization. We need large prospective studies to discern the association between anemia and COPD. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4372868/ /pubmed/25814799 http://dx.doi.org/10.4103/0970-2113.152626 Text en Copyright: © Lung India http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Sarkar, Malay Rajta, Puja Negi Khatana, Jasmin
spellingShingle	Sarkar, Malay Rajta, Puja Negi Khatana, Jasmin Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact
author_facet	Sarkar, Malay Rajta, Puja Negi Khatana, Jasmin
author_sort	Sarkar, Malay
title	Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact
title_short	Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact
title_full	Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact
title_fullStr	Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact
title_full_unstemmed	Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact
title_sort	anemia in chronic obstructive pulmonary disease: prevalence, pathogenesis, and potential impact
description	Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable lifestyle-related disease with high global prevalence. COPD is associated with significant morbidity and mortality worldwide. Comorbidities are important events in the natural history of the disease and have a negative effect on the morbidity and mortality of COPD patients. Cardiac diseases, lung cancer, osteoporosis, and depression are common comorbidities reported for COPD. Recently, anemia has been recognized as a frequent comorbidity in COPD patients. The prevalence of anemia in patients with COPD varies from 7.5% to 33%. Anemia of chronic disease (ACD) is probably the most common type of anemia associated with COPD. ACD is driven by COPD-mediated systemic inflammation. Anemia in COPD is associated with greater healthcare resource utilization, impaired quality of life, decreased survival, and a greater likelihood of hospitalization. We need large prospective studies to discern the association between anemia and COPD.
publisher	Medknow Publications & Media Pvt Ltd
publishDate	2015
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372868/
_version_	1613203183748775936

Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact

Similar Items